Furthermore, the advantages of targeting PAPP-A in breast cancer is that it is more selective in blocking IGF receptor signalling with high specificity and low off-target effects due to PAPP-A’s more restricted expression profile in normal tissue34. This evidence concerns the gene PAPPA and breast cancer.